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ABSTRACT*
Selective reaction monitoring (SRM) has become one of the main methods for low-mass range
targeted proteomics by mass spectrometry (MS). However, in most SRM-MS biomarker valida-
tion studies the sample size is very small, and in particular smaller than the number of proteins 
measured in the experiment. Moreover, the data can be noisy due to a low number of ions de-
tected per peptide by the instrument. In this paper, those issues are addressed by a model-based 
Bayesian method for classification of SRM-MS data, which relies on the SRM model proposed by 
Esmaeil[1] and collaborators and builds a kernel classifier, similarly to the classifier for LC-MS 
data proposed by Banerjee and Braga-Neto[3]. The methodology is likelihood-free, using Ap-
proximate Bayesian Computation (ABC) implemented via a Markov Chain Monte Carlo (MCMC) 
procedure and a kernel-based Optimal Bayesian Classifier (OBC). Extensive experimental results 
demonstrate that the proposed method is superior to classical methods, such as LDA and 3NN, 
when sample size is small, dimensionality is large, the data are noisy, or a combination of these.
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1. INTRODUCTION*
Proteomics is the field which deals with the study of cellular behavior and human disease at the
protein level. Recently, cancer treatment and prevention have made great strides, thanks to the de-
velopment of high-throughput technologies in proteomics. Among these, mass spectrometry (MS) 
analysis has become the preferred choice because of advantages such as high molecular specificity
and better detection sensitivity[6]. Hence, MS is widely used in identification and quantification 
of complex proteome mixtures with the goal of discovering biomarkers, ie, molecular markers for 
disease[5].
However, a major challenge in biomarker discovery is the identification of low-abundance pro-
teins in peripheral blood. Selected reaction monitoring (SRM), conducted using a triplequadrupole 
(QQQ) instrument, has an extended mass range and has become one of the main methods for low-
mass-range targeted proteomics by MS[1].
Nevertheless, in most SRM-MS biomarker validation studies, the sample size is very small due 
to the economic cost of the experiments and difficulty in recruiting c ases. Typically, the number 
of features (measured proteins) is vastly larger than the sample size. Moreover, depending on the 
instrument sensitivity, the data can be noisy due to low peptide efficiency, ie, low number of ions 
detected per peptide.
All the aforementioned issues create a difficult challenge to classical data-driven classification 
methods. In this article, this is addressed by a model-based Bayesian method for classification of 
SRM-MS data. We perform Bayesian inference of the parameters of the SRM model proposed 
in the work by Atashpaz-Gargari et al[7] and build a kernel classifier, similar to the classifier
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for liquid chromatography-mass spectrometry (LC-MS) data proposed in the work by Banerjee
and BragaNeto[3]. As in the latter reference, our method uses a likelihoodfree approach, called
approximate Bayesian computation (ABC)[8-10] which is necessary because the SRM model of
Atashpaz-Gargari et al[5] is complex and does not have an analytical formulation of the likelihood.
After calibration of the parameters, the ABC method is implemented via a Markov chain Monte
Carlo (MCMC) procedure[13,15] to obtain a sample from the posterior distribution of the protein
concentrations. Small MCMC sample sizes are sufficient to obtain a kernel-based implementation
of the Optimal Bayesian Classifier (OBC).[12] Extensive experimental results examining the effect
of various parameters demonstrate that the proposed method outperforms classical methods such
as linear discriminant analysis (LDA) and 3NN[9], when sample size is very small, dimensionality
is large, the data are noisy, or a combination of these
1.1 Organisation
The organization of the article is as follows. Chapter 2: SRM based MS model surveys the
SRM-MS model. Chapter 3: ABC MCMC classification algorithm explains in detail the ABC
rejection algorithm and the approximate Bayesian computation Markov chain Monte Carlo (ABC-
MCMC) classifier. Section Chapter 4:Numerical experiments and results presents the numerical
results. Chapter 5: Conclusions presents concluding remarks.
2
2. SRM-BASED MS MODEL*
In this article, we employ the model for the SRM pipeline proposed in the work by Atashpaz-
Gargari et al [7].Next, we review briefly each of the main components of this model.
2.1 Protein Mixture Model
The protein mixture model concerns the true abundance of proteins in the SRM experiment.
There are n samples in each class; for convenience, the two classes are labeled as 0 for control
and 1 for treatment. There are Napro proteins, N
c
pro of which are low-abundance candidates for
biomarker validation. Protein identities are input as a FASTA file. As argued in previous works[1]
, protein concentration can be modeled by a gamma distribution. Hence, the protein concentration
is given by
γi ∼

Γ(kc, θc) , i = 1, 2, 3, . . . , N
c
pro ,
Γ(ka, θa) , i = N
c
pro + 1, N
c
pro + 2, . . . , N
a
pro .
(2.1)
The variables k and θ are respectively shape and scale parameters. These are uniform ran-
dom variables defined as kc ∼ Unif(klowc ,khighc ), Unif(klowa ,khigha ) and θc ∼ Unif(θlowc , θhighc ) , θa ∼
Unif(θlowa , θ
high
a ) respectively. The initial values of these variables, which are displayed in Table 1,
reflect the dynamic range of protein abundance levels while taking into account that the candidate
proteins are expressed at a much lower level than the background proteins. The initial values used
here are consistent with values obtained experimentally in the work by Taniguchi et al as well as
the hyperparameter values used in the work by Atashpaz-Gargari et al [7]. Furthermore, these
initial values are modified b ased o n t he d ata, a s p art o f t he p rior c alibration p rocess d escribed in
Algorithm 1.
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Parameter Symbol Value/Range
Instrument response factor κ 5
Noise severity α, β 0.03,3.6
Shape(Gamma distribution) ka, kc Unif(1.6,2.4), Unif(4,6)
Scale(Gamma Distribution) θa, θc Unif(9e6,11e6), Unif(90,110)
Purification ηi 10−6
Coefficient of Variation φ Unif(0.3,0.5)
Fold change f Unif(1.5,1.6)
peptide efficiency factor ei [0.1,1]
Table 2.1: SRM Instrument parameters
Proteins are divided into biomarker (differentially expressed) and nonbiomarker (not differen-
tially expressed) proteins. We use fold change to quantify the difference:
fl =

ai , if the protein i is over expressed,
1
ai
, if the protein is under expressed,
1, otherwise,
(2.2)
for l = 1, . . . , Napro. The fold change parameter ai is uniformly distributed in the interval [1, h], for
h > 1. The value of h used here is displayed in Table-1.
While the gamma distribution is chosen for mean protein concentrations, the variation of pro-
tein concentration is modeled by a multivariate gaussian vector. Accordingly, the concentration of
protein l in class j is modeled as follows:
Cproij ∼

N([γ1, γ2 . . . , γNapro)],Σ) , for j ∈ class 0,
N([γ1f1, γ2f2 . . . , γNaprofNapro)],Σ) , for j ∈ class 1,
(2.3)
for l = 1, . . . , Napro. Here we consider a diagonal covariance matrix Σ = [σ
2
lk]NproXNpro so that the
4
protein concentrations are mutually independent or very weakly correlated (correlation between
proteins can be included at the cost of adding more parameters to the model):
Σ =

σ211 0 0 . . . 0
0 σ222 0 . . . 0
. . . . . . .
. . . . . . .
0 0 0 . . . σ2Napro

, (2.4)
where
σ2ij =

σ2ii, if i = j and i, j = 1, . . . , N
a
pro
0, otherwise,
(2.5)
and
σ2ii = φ ∗ γ2ii, i = 1, . . . , Napro . (2.6)
The coefficient of variation φ has the initial value displayed in Table 1, which is the same as the
one used in the work by Banerjee and Braga-Neto[1]. This value is modified based on the data, as
part of the prior calibration process described in Algorithm 1. To model the purification process
usually performed as part of the SRM-MS protocol, we select a set Gp of high-abundance proteins
to be removed (in fact, attenuated) from the protein mixture:
C p̂roij =

ηiC
pro
ij , for i ∈ Gp,
Cproij , otherwise.
(2.7)
The value for ηi corresponds to the efficiency of the purification process and should be very small.
See Table 1 for the value used in our simulation.
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2.2 Peptide mixture model
In SRM-MS, tryptic digestion of proteins is carried out to generate small-mass peptides. Let
Ωi be the set of all the proteins which contain the i-th peptide.
Cpepij =
∑
k∈Ωi
C p̂rokj i=[1,2,. . . N
pp
c ], j ∈[0,1] (2.8)
The readout abundance µij of the peptide can be modeled as
µij = C
pep
ij eiκ (2.9)
Here ei represents the peptide efficiency factor and κ represents the SRM-MS response factor.
However, the true peptide abundance is different from its readout value due to the noise:
νij = ij + λij i=[1,2,. . . Nppc ], j ∈[0,1] (2.10)
where ij is the additive gaussian noise which has a quadratic dependence on µij as given below:
ij ∼ N(0, αµ2ij + βµij) i=[1,2,. . .Nppc ], j ∈[0,1] (2.11)
where λij is the additive exponential noise introduced due to transition effects.
λij ∼ exp(µtranµij) (2.12)
where µtran is a fixed constant.
The next step is called protein abundance roll-up. This is the process of obtaining the abun-
dances of the parent proteins from the abundances and related characteristisc of their child peptides,
detected during the MS1 process. To obtain the identities of the parent proteins, a second round
of MS, called MS/MS, is often used and available databases of identities are searched. Here, we
assume that the data from the rolled up abundances can be obtained and the readout of protein l in
6
sample j is given by
xlj =
1
κηl
∑
i∈Nl
νlj l=[1,2,. . .Npro], j ∈[0,1] (2.13)
Where κ is the instrument response factor, Nl is the set of proteins present in peptide l and ηl is the
number of peptides in set Nl. The data xlj obtained in equation 2.13 are used for classification.
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3. ABC-MCMC CLASSIFICATION ALGORITHM*
As described in the introduction section, the algorithm mainly has 3 steps: prior calibration via
ABC rejection sampling, posterior sampling using an ABC-MCMC algorithm, and classification
using a kernel-based method. We describe each of these steps below
3.1 Prior calibration via ABC rejection sampling
Once the protein abundances as described in equation (2.7) are obtained, the total number of
proteins N pro a is reduced via a feature selection algorithm. As per the equations in the previous
section, the protein abundance profiles are a function of the following:
• baseline parameters γ = [γ1, γ2 . . . ..γd]
• Prior hyperparameters: ka, kc, θa, θc, φ, f
• Instrument parameters: κ, α, β, ei
Prior calibration via ABC rejection sampling is as described in Algorithm 1. Monte Carlo
integrations are performed to obtain a set of parameters and only some of them are kept and rest
are rejected via comparing with a threshold.In this algorithm  is the error tolerance. This has to
be chosen optimally so that it should not be too high for bad samples to be accepted or it should
not be very small that all the samples are accepted, i.e. P (‖T(S(t)0 ),T(S0)‖ < ) ≈ 0 .Once
the optimal parameters are obtained, the fold change vector is calculated by the following sample
mean estimate:
fl,cal =
Tl(S1)
Tl(S0)
, l=0,1,2. . . ,d (3.1)
where Tl denotes the l-th sample mean for the selected protein only.
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Algorithm 1 Prior calibration of kc, ka, θc, θa, φ using ABC Rejection sampling
1. Generate Mcal quintuplets of parameters of kc, ka, θc, θa, φ such that,
k
(t)
a ∼ Unif(klowa , k
high
a )
k
(t)
c ∼ Unif(klowc , k
high
c )
θ
(t)
a ∼ Unif(θlowa , θ
high
a )
θ
(t)
c ∼ Unif(θlowc , θ
high
c ),
φ(t) ∼ Unif(φlow, φhigh)
for t = 1, 2, . . . ..Mcal
2. Now simulate a control sample set S(t)0 of size n for each quintuplet of parameters for t=1,2. . . .Mcal
3. Accept the quintuplet (k(t)a , k
(t)
c , θ
(t)
a , θ
(t)
c , φ
(t)
a ) if ‖T(S(t)0 ) − T(S0)‖ <  , for t = 1, 2 . . . .Mcal. Here
‖‖ denotes the Euclidean norm and T denotes vector sample mean.
4. Let B=[(k1, θ1, φ1), . . . ., (kna , θna , φna)] be the set of accepted triplets.
5. The calibrated k can be approximated as follows:
kcala =
khigha∫
klowa
kp(ka|Sn)dk = 1na
na∑
a=1
kcala
6. Similarly other four parameters are also calculated
3.2 ABC-MCMC Posterior Sampling
ABC-MCMC sampling is as described in Algorithm 2. Vector γ=(γ1, γ2 . . . .γd) is sampled
from p(γ|Sn) ∝ p(Sn|γ)p(γ). After a burn-in period for the Markov chain of ts, the next M
samples from ts to ts +M are considered as the generated data. Proper selection of the thresholds
in step 4 of Algorithm 2 plays a very important role in the performance of the ABC-MCMC
algorithm.
9
Algorithm 2 Obtain the posterior samples of γ using ABC-MCMC algorithm
1. Generate the mean vector γ(0) = (γ0, γ1, . . . γd) from the Γ distribution with optimal parameters
generated in algorithm 1.
For t=0,1,. . . ts, ts+1, . . . .ts +M where ts is the burn-in period do:
2. Generate γ(t+1)= ColMeans(S(t)0 ) where ColMeans is a function which calculates mean
feature(protein) wise.
3. Simulate the control and treatment samples St+10 and S
t+1
1 each of size using γ
(t+1) and
γ(t+1).fcal respectively.
4. Let
q=
{
1 ‖T(S(t+1)0 )− T(S0)‖ < 0 and ‖T(S(t+1)1 )− T(S1)‖ < 1
0 otherwise
5. If q=1, accept γ(t+1) else γ(t+1) = γ(t)
3.3 Kernel-Based Classification
We employ the kernel-based scheme proposed in the work by Banerjee and Braga-Neto,[3]
which is itself based on the OBC in Dalton and Dougherty.[12] One of the issues with kernel based
classification is choosing the right value of the kernel bandwidth parameter. If the value of the
bandwidth parameter chosen is high, then it leads to oversmoothing and thus hiding many details in
the data distribution. However, a small value for the bandwidth parameter leads to undersmoothing
and thus many spurious noisy elements in the data are not eliminated. To address this, we employ
an ensemble method, where different classifiers with different bandwidth parameters are obtained
and then majority vote is used for classification. The classification algorithm is described in detail
in Algorithm 3.
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Algorithm 3 Using the ABC-MCMC based posterior samples for classification.
1. Choose a set of kernel bandwidth parameters h = (h1, h2, . . . , hf ) where f is the number of
bandwidth values taken.
2. Choose the number of γ samples from markov chain to be used in the kernel classifier. Say
we select q samples from the posterior. It is advisable to choose the samples from the end. For
example in this case ts +M − q to ts +M .
3. Choose a suitable kernel K for the analysis. In this paper we have chosen a zero mean unit
variance gaussian kernel.
4.For a given test point x do:
. Declare a result vector res_vec=zeros[length(h)]
. For i in h1, h2, . . . , hf do:
. if (c
ts+M∑
t=ts+M−q
n∑
j=1
K(x−x(j)
hi
) ≥ (1− c)
ts+M∑
t=ts+M−q
2n∑
j=n+1
K(x−x(j)
hi
))
. res_vec[i]=1
. else
. res_vec[i]=0
5. The kernel based classifier is now given by,
Ψ(x) =
{
1 if sum(res_vec) ≥ f+1
2
.
0 otherwise
(3.2)
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4. NUMERICAL EXPERIMENTS AND RESULTS*
In this section we demonstrate the application of proposed ABC-MCMC classification algo-
rithm for SRM data, using a synthetic dataset generated from a subset of the human proteome. We
selected a list of proteins from the Drugbank and applied tryptic digestion of proteins using the
OpenMS software [1]. Since our interest is in small sample sizes we chose simple classification
rules, which are known to perform well with small samples, for comparison: Linear discriminant
analysis (LDA) and K-Nearest neighbor (KNN) with K=3.
Synthetic SRM-MS data were generated by the model described in section-2, using the param-
eters in Table-1. Synthetic sample data for prior calibration were generated using the midpoint of
the intervals specified in Table-1. For example, since φ ∼ Unif(0.3,0.5), we take 0.4 as the initial
value.
For the MCMC procedure, we consider 10000 samples from the posterior distribution of γ. A
burn-in stage of around 3000 iterations is considered. The value of prior probability was taken to
be 0.5 (equally-likely classes). Kernel density estimation is based on 15 MCMC samples of γ, i.e
q=15 in Algorithm 3 (increasing this number did not show any significant difference in the results).
From the initial number of 350 proteins, a t-test is applied to select the top 10-15 proteins. The
t-test can select the protein features erroneously as opposed to more sophisticated feature selection
methods, which makes the experiment more realistic.
We consider sample sizes n = 10 through n = 40 per class, and select the number of features
to be d = 3, 5, 8, 10. A total of 6 runs of the experiment are conducted for each combination of
classification rule, sample size, and dimensionality, and the average error for each case is obtained
via a synthetic test dataset of 100 sample points
*Reprinted with permission from Bayesian Classification of Proteomics Biomarkers from Selected Reaction 
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4.1 Effect of Sample size
Figure 4.1: Variation of estimated error rate by number of samples.
Figure 1 displays the average error rates for the different classification rules. The number
of proteins selected is fixed at d = 10. With the increase in sample size we see that the total
error decreases for all classification rules. An important observation is that at small sample sizes,
the performance of ABC-MCMC is best, confirming the general principle of good small-sample
performance by Bayesian methods.
4.2 Effect of Dimensionality
The average error rates of the various classification rules against dimensionality, ie, number of
selected proteins, are displayed in Figure 2, for fixed sample size n = 10 per class. We can observe
a very strong peaking phenomenon16: as the number of selected proteins increases, the average
classification error rates tend to go down at first, but then increase sharply, due to the small sample
13
Figure 4.2: Variation of estimated error rate by the values of Dimensionality .
size, ie, small ratio between number of points over the dimensionality. One can observe that the
ABC-MCMC classification rule is the most accurate one when d is large, which is in agreement
with the fact that Bayesian methods tend to outperform competing techniques under small ratios
of sample size to dimensionality.
4.3 Effect of Variability
Here, we keep the sample size at n = 10 and the number of features at d = 8 to investigate
the impact on the classification of error rate of an increasing variability of the true protein con-
centration values. In Figure 3, one can observe that the performance of all classification rules
degrades with increasing values of the coefficient of variation φ ; however, the performance of the
ABC-MCMC algorithm is uniformly better than the others due to the small sample size n = 10 .
4.4 Effect of Peptide Efficiency
Finally, we investigate the impact on the classification accuracy of varying the peptide effi-
ciency. The peptide efficiency factor a controls how many ions can be detected for a given peptide.
Increasing this parameter uniformly increases efficiency for all peptides, which corresponds to
a more accurate SRM-MS experiment. Indeed, one can observe in Figure 4 that classification
14
Figure 4.3: Variation of estimated error rate by the values of φ .
accuracy tends to increase with increasing peptide efficiency. One can also observe that the ABC-
MCMC classification rule displays the smallest error rates among the competing methods at low
peptide efficiency, ie, in a more noisy experiment.
15
Figure 4.4: Variation of estimated error rate by the values of peptide efficiency .
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5. CONCLUSIONS*
We have proposed a Bayesian approach for classifying SRM data with the goal of facilitating
biomarker development. This method is a combination of ABC and MCMC. We can see that for
small sample sizes, large dimensionality, or noisy data, the performance of the proposed Bayesian
classifier is superior to that of other approaches. Our results are based on a subset of the human
proteome selected from the Drugbank, which are submitted to tryptic digestion in silico. In addi-
tion, the prior hyperparameters are calibrated using the available data. This makes the the approach
realistic and broadly applicable. Because we are studying the effects of the various parameters of
the SRM pipeline on the classification error, there is a need to use synthetic data from a generative
model. The results are, however, expected to be reproducible on clinical SRM data.
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